Document is current
Any future updates will be listed below
-
Authors
Corden, Ben https://orcid.org/0000-0003-2136-2994
Lim, Wei-Wen
Song, Weihua
Chen, Xie
Ko, Nicole S. J.
Su, Liping
Tee, Nicole G. Z.
Adami, Eleonora
Schafer, Sebastian
Cook, Stuart A.
-
Funding
Funding for this research was provided by:
National Medical Research Council (NMRC/STaR/0029/2017)
- License Information
-
More Information
Article History
Received: 28 April 2020
Accepted: 15 June 2020
First Online: 26 June 2020
Compliance with Ethical Standards
:
: SAC and SS are co-inventors of patent applications (WO/2017/103108: TREATMENT OF FIBROSIS, WO/2018/109174: IL-11 ANTIBODIES, WO/2018/109170: IL-11RA ANTIBODIES). SAC and SS are co-founders of Enleofen Bio PTE LTD, a company developing anti-IL11 therapeutics. All other authors declare that they have no conflicts of interest.
: All applicable international, national and institutional guidelines for the care and use of animals were followed. This article does not contain any studies with humans performed by any of the authors.
